Cite
MLA Citation
Midori Shima et al.. “A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.” Haemophilia, vol. 25, no. 6, 2019, pp. 979–987. http://access.bl.uk/ark:/81055/vdc_100098050317.0x00002d